期刊文献+

洛铂联合香菇多糖治疗恶性胸腔积液临床观察 被引量:7

Clinical Observation of Malignant Pleural Effusion of Lobaplatin Combined Treatment of Lentinan
下载PDF
导出
摘要 目的:观察胸腔内置管注入洛铂和香菇多糖治疗恶性胸腔积液的疗效。方法:收治恶性胸腔积液60例,随机数字表法分为两组,经皮胸腔内置管引流尽胸液后,治疗组30例予胸腔内注入洛铂50 mg+香菇多糖4 mg,对照组30例予顺铂40 mg/m2注入胸腔。结果:治疗组总有效率和生活质量改善率均优于对照组(P<0.05)。两组毒副作用相近。结论:洛铂联合香菇多糖胸腔内化疗治疗恶性胸腔积液安全有效。 Objective: To observe lobaplatin the effectiveness and adverse reaction in the treatment of malignant pleural effusion by injection to thoracic cavity with lentinan combined with lobaplatin or cisplatin alone. Method: 60 patients with malignant pleural effusion were divided into two groups, percutaneous intrathoracie drainage to pleural effusion, 30 cases in the treatment group were treated with intrapleural injection of lobaplatin 50 mg + lentinan 4 mg, 30 cases in the control group treated with cisplatin 40 mg/m2 was injected into the pleural cavity. Result: The total effective rate and the improvement rate of life quality was better than that of the control group, with significant differences ( P〈0.05 ) . The two groups had similar side effects. Conclusion: Chest tube rows of lobaplatin combined with mushrooms polysaccharide perfusion is safe and effective in the treatment of malignant pleural effusion, operation is convenient, effective, less adverse reactions, especially suitable for patients with advanced cancer through multiple platinum chemotherapy with pleural effusion.
作者 贺敏 何兴鸿
出处 《中国医学创新》 CAS 2014年第22期80-82,共3页 Medical Innovation of China
关键词 洛铂 顺铂 香菇多糖 恶性胸腔积液 Lobaplatin Cisplatin Lentinan Malignant pleural effusion
  • 相关文献

参考文献8

二级参考文献71

共引文献106

同被引文献69

  • 1Jakupec M A, Galanski M, Keppler B K. Turnout-inhibiting platinum complexes state of the art and future perspectives [J]. Rev Physiol Biochem Pharmacol, 2003, 146: 1-53.
  • 2Monneret C. Platinum anticancer drugs. From serendipity to rational design [J]. Ann Pharm Fr. 2011, 69(6): 286-295.
  • 3贺敏.中心静脉导管闭式引流联合顺铂或洛铂心包腔灌注治疗恶性心包积液的疗效比较【C]//第13届全国肺癌学术大会论文汇编.2013:211.
  • 4黎鹏,王树堂,林丽珠.重组人p53腺病毒注射液联合洛铂冶疗恶性胸腔积液[J].医药前沿,2013,(15):165.
  • 5张丽,张恒,韩斌,等.洛铂和五昧子多糖胸腔内注射在肺癌伴胸腔积液治疗中的应用[J】.中国保健营养,2012,13:484-485.
  • 6Hazama S, Watanabe S, Ohashi M, et al.Efficacy of orally administered superfine dispersed lentinan(beta-l, 3-glucan) for the treatment of advanced colorectal cancer[J].Anticancer Res, 2009, 29(7): 2611-2617.
  • 7Mitamura T, Sakamoto S, Suzuki S, et al.Effects of lentinan on coloreetal carcinogenesis in mice with ulcerative colitis[J].Oncol Rep, 2000, 7(3): 599-601.
  • 8Marino P, Pampallona S, Preatoni A, et al.Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a recta-analysis oftheliterature[J].Chest, 1994, 106(3): 861-865.
  • 9Kosaka A, Kuzuoka M, Yamafuji K, et al.Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans[J].Gan To Kagaku Ryoho, 1987, 14(2): 516-522.
  • 10Maeda Y Y, Chihara G.Lentinan, a new immuno-accelerator of cell- mediated responses[J].Nature, 1971, 229(5287): 634.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部